Fig. 1h ). ( h ) RT-qPCR gene expression analysis of OSMR, ICAM1 , and GPC6 in O-PCOS (purple) and O-Ctrl (blue) EEOs at baseline as relative to HPRT1 and GAPDH expression. ( i ) Representative images of immunostaining of OSMR (green) in O-EEOs of Ctrl and PCOS at baseline. Blue indicates DAPI-stained nuclei, scalebar = 100 µm. ( j ) Proportion of OSMR-positive cells in O-PCOS (purple) and O-Ctrl (blue) O-EEOs. N = 4 independent EEO cultures from different donors per group. EEOs from low passage ( P ≤ 5) were used. Student’s t -test or Mann–Whitney test; *= P < 0.05; ***= P <0.001. Data are presented as mean±SEM. " width="100%" height="100%">
Journal: Human Reproduction (Oxford, England)
Article Title: PCOS endometrium-derived epithelial organoids as a novel model to study endometrial dysfunction
doi: 10.1093/humrep/deaf113
Figure Lengend Snippet: Establishment and characterization of O-PCOS and O-Ctrl endometrium epithelial organoids (EEOs). ( a ) Hormone exposure protocol. EEOs were cultured for 8 days without hormones (baseline), or exposed to 10 nM β-estradiol (E2 exposure) for 6 days, or exposed to 10 nM E2 for 2 days, followed by 4-day exposure to a combination of 10 nM E2, 1 µM progesterone (P4), 0.25 mM cyclic adenosine monophosphate (cAMP), and 10 µM XAV-939 (EPCX exposure), all in the presence/absence of 100 nM dihydrotestosterone (DHT). ( b ) Representative brightfield images of overweight/obese PCOS (O-PCOS) or control (O-Ctrl) EEOs during 8-day culture without hormone exposure; scalebar = 200 µm. ( c ) Representative images of hematoxylin and eosin (H&E) staining and immunostaining for CDH1 (red) in EEOs and in endometrial (endom.) tissue as positive control. Blue indicates DAPI-stained nuclei, scalebar = 50 µm. ( d, e ) Volcano plots of differentially expressed genes (DEGs; adjusted P -value ( P .adj.)<0.05) in O-Ctrl EEOs after E2 (d) or EPCX exposure, (e) compared to non-exposed (baseline) Ctrl EEOs. Log2(FC), Log2(fold change). Green and blue dots indicate significantly up- and downregulated expression, respectively; gray dots denote non-significant changes. ( f ) Gene ontology (GO) enriched pathways ( P .adj.<0.05) in O-PCOS versus O-Ctrl EEOs at baseline. Green and blue bars represent up- and downregulated pathways, respectively. ( g ) Volcano plot of DEGs ( P .adj.<0.05) between O-PCOS and O-Ctrl EEOs after 8-day culture at baseline. Genes in bold were validated using RT-qPCR (see Fig. 1h ). ( h ) RT-qPCR gene expression analysis of OSMR, ICAM1 , and GPC6 in O-PCOS (purple) and O-Ctrl (blue) EEOs at baseline as relative to HPRT1 and GAPDH expression. ( i ) Representative images of immunostaining of OSMR (green) in O-EEOs of Ctrl and PCOS at baseline. Blue indicates DAPI-stained nuclei, scalebar = 100 µm. ( j ) Proportion of OSMR-positive cells in O-PCOS (purple) and O-Ctrl (blue) O-EEOs. N = 4 independent EEO cultures from different donors per group. EEOs from low passage ( P ≤ 5) were used. Student’s t -test or Mann–Whitney test; *= P < 0.05; ***= P <0.001. Data are presented as mean±SEM.
Article Snippet: For immunofluorescent staining of PR (1/300, Proteintech, USA, 25871-1-AP), and Oncostatin M Receptor (OSMR) (1/100, Proteintech, 10982-1-AP), slides were blocked for 1 h before primary and secondary antibody exposure using 5% donkey serum (Sigma-Aldrich) and 0.1% Tween 20 in Tris-buffered saline.
Techniques: Cell Culture, Control, Staining, Immunostaining, Positive Control, Expressing, Quantitative RT-PCR, Gene Expression, MANN-WHITNEY